Analyst Ratings for Stoke Therapeutics (STOK)
STOK Rating Summary
STOK Price Target Summary
- Highest: $60.00 (Canaccord)
- Lowest: $35.00 (Chardan)
- Average: $45.11
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$45.11 (+54%)
* Over Last 12-Mos
Rating Score: 7.6 / 10
Percentile Rank: 80%
Avg. $ Target:
$45.11 (+54%)
* Over Last 12-Mos
Rating Score: 7.6 / 10
Percentile Rank: 80%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/13/2026 | Goldman Sachs | Kevin Strang | New Coverage | Buy (N/A) |
44.00 (N/A) |
31.38 (29.30) |
-6.63% | Details |
| 2/24/2026 | Wolfe Research | Rudy Li | New Coverage | Outperform (N/A) |
40.00 (N/A) |
34.29 (29.30) |
-14.55% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
